HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John A Blessing Selected Research

NSC 366140 (pyrazoloacridine)

8/2002A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
2/2002Phase II trial of pyrazoloacridine in recurrent platinum-resistant ovarian cancer: a Gynecologic Oncology Group study.
2/2002Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
1/2002Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John A Blessing Research Topics

Disease

20Neoplasms (Cancer)
09/2014 - 01/2002
18Carcinoma (Carcinomatosis)
09/2014 - 02/2003
12Endometrial Neoplasms (Endometrial Cancer)
04/2011 - 02/2002
12Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2007 - 04/2002
10Ovarian Neoplasms (Ovarian Cancer)
05/2012 - 01/2002
9Leiomyosarcoma
10/2014 - 01/2002
7Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2012 - 04/2002
6Disease Progression
09/2014 - 09/2003
4Neutropenia
12/2012 - 08/2002
3Ovarian Epithelial Carcinoma
10/2010 - 08/2003
3Carcinosarcoma
08/2010 - 05/2004
3Thrombocytopenia (Thrombopenia)
11/2005 - 04/2003
2Breast Neoplasms (Breast Cancer)
01/2010 - 02/2003
2Anemia
11/2006 - 07/2003
2Nausea
11/2006 - 07/2003
2Vomiting
11/2006 - 07/2003
2Adenocarcinoma
08/2005 - 08/2004
1Pneumonia (Pneumonitis)
06/2008
1Hypoxia (Hypoxemia)
06/2008
1Hypersensitivity (Allergy)
03/2008
1Exanthema (Rash)
03/2008
1Cardiotoxicity
08/2005
1Fatigue
01/2005
1Hypertension (High Blood Pressure)
01/2005
1Renal Insufficiency (Renal Failure)
08/2004
1Clinical Deterioration
06/2002

Drug/Important Bio-Agent (IBA)

18PlatinumIBA
12/2012 - 01/2002
12Cisplatin (Platino)FDA LinkGeneric
09/2014 - 04/2002
8GemcitabineFDA Link
10/2014 - 02/2004
7Docetaxel (Taxotere)FDA Link
10/2014 - 02/2003
6Paclitaxel (Taxol)FDA LinkGeneric
07/2009 - 02/2003
5Pharmaceutical PreparationsIBA
12/2012 - 07/2003
5Doxorubicin (Adriamycin)FDA LinkGeneric
06/2008 - 06/2002
4Pemetrexed (MTA)FDA Link
09/2014 - 07/2008
4Topotecan (Hycamtin)FDA LinkGeneric
11/2009 - 12/2002
4NSC 366140 (pyrazoloacridine)IBA
08/2002 - 01/2002
3ixabepilone (BMS 247550)FDA Link
10/2014 - 07/2009
3Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2006 - 07/2003
3liposomal doxorubicin (Doxil)FDA Link
08/2006 - 05/2002
3Vinorelbine (Navelbine)FDA LinkGeneric
01/2005 - 02/2004
2taxaneIBA
10/2014 - 01/2010
2Carboplatin (JM8)FDA LinkGeneric
05/2012 - 03/2008
2irofulvenIBA
10/2010 - 08/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2008 - 06/2008
2ParaffinIBA
03/2007 - 03/2005
2Capecitabine (Xeloda)FDA Link
03/2007 - 03/2005
2RNA (Ribonucleic Acid)IBA
03/2007 - 01/2002
2Thymidine PhosphorylaseIBA
03/2007 - 03/2005
2Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
03/2007 - 03/2005
2AnthracyclinesIBA
08/2006 - 05/2002
2Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2005 - 06/2002
2CreatinineIBA
05/2003 - 04/2003
2Trimetrexate (JB11)FDA Link
05/2002 - 01/2002
1acivicin (AT 125)IBA
12/2012
1Albumin-Bound PaclitaxelFDA Link
12/2012
1130-nm albumin-bound paclitaxelIBA
12/2012
1Drug CombinationsIBA
12/2012
1Histone Deacetylase InhibitorsIBA
05/2012
1belinostatIBA
05/2012
1TrabectedinIBA
01/2012
1epothilone B (EPO906)IBA
01/2010
1Bortezomib (Velcade)FDA Link
11/2009
1Investigational DrugsIBA
07/2009
1ErbB Receptors (EGF Receptor)IBA
03/2008
1Cetuximab (Erbitux)FDA Link
03/2008
1CR 6IBA
03/2008
1Biomarkers (Surrogate Marker)IBA
03/2007
1sargramostim (Leukine)FDA Link
11/2005
1Dacarbazine (DIC)FDA LinkGeneric
11/2005
1alvocidib (flavopiridol)IBA
08/2005
1Thymidylate SynthaseIBA
03/2005
19-aminocamptothecinIBA
01/2005
1Irinotecan (Camptosar)FDA LinkGeneric
08/2004
1ElectrolytesIBA
08/2004
1Platinum Compounds (Compounds, Platinum)IBA
09/2003
1Etoposide (VP 16)FDA LinkGeneric
05/2003
1A 7 (A-7)IBA
05/2003
1BilirubinIBA
04/2003
1A-factor (Streptomyces)IBA
06/2002
11-dodecylpyridoxal (PLD)IBA
05/2002
12-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
05/2002
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2002
1IfosfamideFDA LinkGeneric
04/2002
1DNA (Deoxyribonucleic Acid)IBA
01/2002
1AcridinesIBA
01/2002
19-methoxyacridineIBA
01/2002

Therapy/Procedure

23Therapeutics
10/2014 - 01/2002
21Drug Therapy (Chemotherapy)
01/2012 - 01/2002
2Drug Tapering
12/2012 - 08/2002
1Treatment Delay
11/2005
1Combination Drug Therapy (Combination Chemotherapy)
08/2004